These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34030767)

  • 1. Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies.
    Winders T; DuBuske L; Bukstein DA; Meltzer EO; Wallace D; Rance K
    Allergy Asthma Proc; 2021 Jul; 42(4):301-309. PubMed ID: 34030767
    [No Abstract]   [Full Text] [Related]  

  • 2. The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy.
    Skoner DP; Blaiss MS; Dykewicz MS; Smith N; Leatherman B; Bielory L; Walstein N; Craig TJ; Allen-Ramey F
    Allergy Asthma Proc; 2014; 35(3):219-26. PubMed ID: 24801464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy.
    Leatherman B; Skoner DP; Hadley JA; Walstein N; Blaiss MS; Dykewicz MS; Craig T; Smith N; Allen-Ramey F
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):779-88. PubMed ID: 25123933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preferences for route of allergy immunotherapy: a comparison of four delivery methods.
    Chester JG; Bremberg MG; Reisacher WR
    Int Forum Allergy Rhinol; 2016 May; 6(5):454-9. PubMed ID: 26833457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO
    Cardell LO; Sterner T; Ahmed W; Slættanes AK; Svärd M; Pollock RF
    Sci Rep; 2024 Jan; 14(1):1575. PubMed ID: 38238479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-life outcomes in patients who underwent subcutaneous immunotherapy and sublingual immunotherapy in a real-world clinical setting.
    Schwanke T; Carragee E; Bremberg M; Reisacher WR
    Am J Rhinol Allergy; 2017 Sep; 31(5):310-316. PubMed ID: 28859707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
    Tabatabaian F; Casale TB
    Allergy Asthma Proc; 2015; 36(2):100-4. PubMed ID: 25715238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance in subcutaneous and sublingual allergen immunotherapy: A nationwide study.
    Borg M; Løkke A; Hilberg O
    Respir Med; 2020; 170():106039. PubMed ID: 32843170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in allergen immunotherapy.
    Vadlamudi A; Shaker M
    Curr Opin Pediatr; 2015 Oct; 27(5):649-55. PubMed ID: 26241500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term health care resource and cost savings with allergy immunotherapy: REACT study results.
    Fritzsching B; Porsbjerg C; Contoli M; Buchs S; Larsen JR; Freemantle N
    J Allergy Clin Immunol Glob; 2024 Feb; 3(1):100197. PubMed ID: 38226187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Versus Subcutaneous Immunotherapy for Allergic Rhinitis: What Are the Important Therapeutic and Real-World Considerations?
    Field K; Blaiss MS
    Curr Allergy Asthma Rep; 2020 Jun; 20(9):45. PubMed ID: 32548677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient initiation and persistence with allergen immunotherapy.
    Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical practice of allergen immunotherapy in Mexico according to 277 allergists who were surveyed during a three-year AIT course].
    Rangel-Garza L; Larenas-Linnemann D; Rodríguez-Pérez N; Ortega-Martell JA; Oyoqui-Flores JJ
    Rev Alerg Mex; 2020; 67(1):1-8. PubMed ID: 32447862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.